Total value in 2020: $2,840.48M (146 completed)

Company Financing type Shares, units or warrants (M) Amount raised (US$M)

March - $1,102.80M

AB Science SA (Paris) Private placement and Warrants exercise 0.86S $13.72
Akari Therapeutics plc (London) Private placement 5.62S $9.50
Armata Pharmaceuticals Inc. (Marina Del Rey, Calif.) Shares purchase 7.71S $22.20
Aytu Bioscience Inc. (Englewood, Colo.) Registered direct offering 7.8S $9.00
Aytu Bioscience Inc. (Englewood, Colo.) Registered direct offering 16S and W for 16S $20.00
Baudax Bio Inc. (Malvern, Pa.) Loan facility N/A N/A
Bellerophon Therapeutics Inc. (Warren, N.J.) Registered direct offering 1.27S $15.30
Biocurepharm Korea (subsidiary of Biocure Technology Inc.; Vancouver, British Columbia) Private placement N/A $0.05
Brainstorm Cell Therapeutics Inc. (New York) Registered direct offering 1.25S $10.00
Bridgebio Pharma Inc. (Palo Alto, Calif.) Convertible senior notes offering N/A $400.00
Cocrystal Pharma Inc. (Bothell, Wash.) Registered direct offering 5S $6.80
Cytodyn Inc. (Vancouver, Wash.) Convertible note financing N/A $15.00
Emmaus Life Sciences Inc. (Torrance, Calif.) Stock purchase agreement 0.1S $2.00
Enlivex Therapeutics Ltd. (Ness Ziona, Israel) Registered direct offering 2.09S and W for 2.09S $16.75
Equillium Inc. (La Jolla, Calif.) Stock purchase agreement N/A N/A
Ethismos Research Inc. (Cambridge, Mass.) Private placement N/A $50.00
Eton Pharmaceuticals Inc. (Deer Park, Ill.) Equity Financing 2.6S $7.80
Eton Pharmaceuticals Inc. (Deer Park, Ill.) Debt financing N/A $2.00
Eyenovia Inc. (New York) Private placement N/A $6.00
Helix Biopharma Corp. (Richmond Hill, Ontario) Private placement 5.04U $4.31
Hemostemix Inc. (Calgary, Alberta) Private placement 254U $1.83
Hemostemix Inc. (Calgary, Alberta) Private placement 17.7U $0.17
IMV Inc. (Dartmouth, Nova Scotia) At-the-market offering N/A N/A
Isofol Medical AB (Gothenburg, Sweden) Rights issue N/A N/A
Lattice Biologics Ltd. (Belgrade, Mont.) Private placement 10U $1.00
Marker Therapeutics Inc. (Houston) Stock purchase agreement N/A N/A
Moberg Pharma AB (Stockholm) Convertible note agreement N/A $0.29
Novan Inc. (Morrisville, N.C.) Registered direct offering 18.6S $8.00
Oncology Venture A/S (Hørsholm, Denmark) Convertible note agreement N/A N/A
Oncoquest Inc., a subsidiary of Quest Pharmatech Inc. (Edmonton, Alberta) Private placement 2.5M $50.00
Pacylex Pharmaceuticals Inc. (Edmonton, Alberta) Convertible note financing N/A $3.90
Plx Pharma Inc. (Sparta, N.J.) Private placement N/A N/A
Predictive Oncology Inc. (Minneapolis) Private placement 1.65S $3.49
Propanc Biopharma Inc. (Melbourne, Australia) Financing agreement N/A $0.45
Protalix Biotherapeutics Inc. (Carmiel, Israel) Private placement 17.6S $43.70
Redx Pharma Ltd. (Alderley Park, U.K.) Loan agreement N/A $6.20
Rockwell Medical Inc. (Wixom, Mich.) Debt financing N/A $22.50
Theravance Biopharma Inc. (Dublin) Private placement N/A $150.00
Titan Pharmaceuticals Inc. (South San Francisco) Warrant exercise 26.2S $5.90
Tonix Pharmaceuticals Inc. (New York) Registered direct offering 14.55S $16.00
Unum Therapeutics Inc. (Cambridge, Mass.) Stock purchase agreement N/A N/A
Vaccinex Inc. (Rochester, N.Y.) At-the-market agreement N/A N/A
Vaccinex Inc. (Rochester, N.Y.) Equity purchase agreement N/A N/A
Vaxart Inc. (South San Francisco) Registered direct offering 4S $10.00
Vaxil Bio Ltd. (Ness Ziona, Israel) Convertible debenture financing N/A $0.13
Vaxil Bio Ltd. (Ness Ziona, Israel) Warrant exercise 3.52S $0.35
Verastem Inc. (Boston) Private placement 46.5S $100.00
Verrica Pharmaceuticals Inc. (West Chester, Pa.) Loan and security agreement N/A $35.00
Vistagen Therapeutics Inc. (South San Francisco) Stock purchase agreement N/A $0.25
Xortx Therapeutics Inc. (Calgary, Alberta) Private placement 18.25U $1.90
Zealand Pharma A/S (Copenhagen) Private placement and directed share issue 0.74S $20.31
Zosano Pharma Corp. (Fremont, Calif.) Registered direct offering 11.9S and W for 11.9S $11.00

No Comments